Armando Sardi Selected Research

Mucinous Adenocarcinoma (Mucinous Carcinoma)

6/2022	Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix.
9/2019	Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin.
7/2019	Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional/Poor Survival After CRS/HIPEC.
2/2019	Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
7/2017	External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Armando Sardi Research Topics

Disease

22	Neoplasms (Cancer) 06/2022 - 01/2002
20	Peritoneal Neoplasms 10/2022 - 01/2012
12	Appendiceal Neoplasms (Appendix Cancer) 10/2022 - 09/2009
6	Neoplasm Metastasis (Metastasis) 10/2022 - 07/2013
6	Carcinoma (Carcinomatosis) 06/2022 - 01/2002
5	Mucinous Adenocarcinoma (Mucinous Carcinoma) 06/2022 - 07/2017
4	Pseudomyxoma Peritonei 01/2021 - 07/2012
4	Sarcoma (Soft Tissue Sarcoma) 06/2018 - 03/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 12/2014
2	Necrosis 01/2022 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 08/2021 - 07/2002
2	Disease Progression 01/2021 - 07/2012
2	Neoplasms, Cystic, Mucinous, and Serous 12/2020 - 12/2020
2	Rectal Neoplasms (Rectal Cancer) 12/2020 - 11/2019
2	Ovarian Epithelial Carcinoma 01/2020 - 07/2002
1	Obesity 01/2021
1	Lymphatic Metastasis 01/2021
1	Necrotizing Fasciitis 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Residual Neoplasm 12/2020
1	Anastomotic Leak 12/2020
1	Pyoderma Gangrenosum 11/2019
1	Signet Ring Cell Carcinoma 02/2019
1	Mesothelioma 12/2015
1	Wounds and Injuries (Trauma) 05/2015
1	Colonic Neoplasms (Colon Cancer) 12/2014
1	Neutropenia 03/2014
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 12/2005
1	Thymoma (Thymic Carcinoma) 12/2005
1	Adenoma (Adenomas) 12/2005
1	Pressure Ulcer (Bedsore) 06/2004
1	Hematoma 12/2003
1	Pneumothorax 12/2003
1	Cardiac Tamponade 12/2003
1	Hemothorax 12/2003
1	Esophageal Neoplasms (Esophageal Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

4	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022 - 12/2014
4	MucinsIBA 12/2020 - 07/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 07/2013
2	Melphalan (Alkeran)FDA LinkGeneric 01/2018 - 03/2014
1	iodoxamic acid (BC 17)IBA 01/2021
1	DeodorantsIBA 01/2021
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 07/2020
1	C-Reactive ProteinIBA 07/2020
1	SPAAT inhibitorIBA 07/2017
1	Biological ProductsIBA 01/2016
1	AlbuminsIBA 05/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2014
1	Tumor Biomarkers (Tumor Markers)IBA 04/2014
1	Filgrastim (Neupogen)FDA Link 03/2014
1	CateninsIBA 07/2013
1	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 01/2002

Therapy/Procedure

37	Hyperthermic Intraperitoneal Chemotherapy 10/2022 - 09/2009
33	Cytoreduction Surgical Procedures 10/2022 - 07/2002
14	Drug Therapy (Chemotherapy) 10/2022 - 07/2002
3	Therapeutics 05/2015 - 01/2002
2	Neoadjuvant Therapy 01/2020 - 12/2015
1	Ileostomy 12/2020
1	Aftercare (After-Treatment) 01/2020
1	Blood Transfusion (Blood Transfusions) 05/2015
1	Sternotomy 12/2005
1	Colostomy 06/2004
1	Punctures 12/2003
1	Catheters 12/2003
1	Esophagectomy 01/2002